Business
BioSpectrum Asia
Next-Gen ADCs as Precision Weapon Against Cancer
Antibody-Drug Conjugates (ADCs) are emerging as a crucial frontier in targeted cancer care. Although the first ADC was approved in 2000, the space has experienced a renaissance in recent times. Major pharmaceutical players like Novartis and Pfizer, including startups, are announcing deals in this space almost every day. Within the Asia-Pacific (APAC) region, China stands at the forefront of ADC drug development. GlobalData reports that numerous domestic companies in China are actively shifting their focus towards the creation of pioneering ADC-based treatment options, particularly for solid tumours like breast, gastric, and bladder cancer. When we observe World Cancer Day on February 4, we explore the promising world of next-gen ADCs, exploring advancements and unravelling the advantages they offer compared to other therapies like cell and gene therapies.
7 min |
BioSpectrum Asia Feb 2024
BioSpectrum Asia
What's Propelling mRNA Therapies Today?
Over the next three to five years, it is anticipated that the portfolio of mRNA treatments and vaccines will grow significantly due to the potential that mRNA has across indications.
6 min |
BioSpectrum Asia January 2024
BioSpectrum Asia
Combating AMR with Bacteriophages
India is among the countries with a high burden of antibiotic-resistant infections.
7 min |
BioSpectrum Asia January 2024
BioSpectrum Asia
"The Open Innovation Program has become a trend in the molecular diagnostics industry"
Established in 2000, South Korea based Seegene Inc is a leader in molecular diagnostics and achieved remarkable financial success with over $1 billion in revenue and 65 per cent gross margins.
5 min |
BioSpectrum Asia January 2024
BioSpectrum Asia
Targeted Battle Against HPV
Since the launch of the global strategy against cervical cancer in 2020, the World Health Organization (WHO) has accelerated the initiative by virtue of commitments and strategies offered by governments and organisations worldwide.
6 min |
BioSpectrum Asia January 2024
BioSpectrum Asia
Tech Trends for Life Sciences to Watch in 2024
Trends to watch in the life sciences industry are ones that support personalised, preventative healthcare, including high quality collection of samples, and the trends in data analysis resulting from the sensitive measurements of thousands of molecules by LC-MS/MS.
2 min |
BioSpectrum Asia January 2024
BioSpectrum Asia
Digitalisation Pharma Tech Trends to look for in 2024
As companies look ahead to 2024 trends, those that are well prepared for the future will not ignore technology and digitalisation trends, but rather find new and valuable ways to leverage them.
2 min |
BioSpectrum Asia January 2024
BioSpectrum Asia
Transformative Life Sciences Trends for 2024
The intersection of tech and healthcare holds immense potential for the life sciences industry.
10+ min |
BioSpectrum Asia January 2024
BioSpectrum Asia
US FDA approves first gene therapies to treat patients with sickle cell disease
The US Food and Drug Administration (FDA) has approved two milestone treatments, Casgevy (Vertex Pharmaceuticals Inc.) and Lyfgenia (Bluebird Bio Inc.), representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older.
1 min |
BioSpectrum Asia January 2024
BioSpectrum Asia
WHO's Science Council issues report on mRNA vaccine technology
Prompted by the life-saving impact of messenger ribonucleic acid (mRNA) vaccines during the COVID-19 pandemic, the World Health Organization's Science Council has released a report reviewing the potential benefits and limitations of mRNA vaccine technology.
1 min |
BioSpectrum Asia January 2024
BioSpectrum Asia
Fujitsu delivers advanced technology to Delight Health for treating delirium
Japan-based Fujitsu and Delight Health, a Bay Area startup, have announced that Fujitsu will licence its Topological Data Analysis (TDA) technology to Delight Health in exchange for an equity position in the company.
1 min |
BioSpectrum Asia January 2024
BioSpectrum Asia
Singapore's Experimental Drug Development Centre inks new collaboration with Chinese startup XtalPi
XtalPi, an innovative technology company powered by artificial intelligence (AI) and robotics from China, has signed a Memorandum of Understanding (MoU) with the Experimental Drug Development Centre (EDDC), Singapore's national drug discovery and development platform hosted by A*STAR, for the expansion of their collaboration to encompass potential projects that will focus on the application of automated synthesis solutions and large language models in pharmaceutical research.
1 min |
BioSpectrum Asia January 2024
BioSpectrum Asia
Nipro partners with FPT Medicare to develop IOMT in Vietnam
Nipro, a multinational medical corporation from Japan, has recently partnered with Vietnam-based FPT Telecom's FPT Medicare on a strategic cooperation agreement to deliver digital medical devices with international standards and affordability.
1 min |
BioSpectrum Asia January 2024
BioSpectrum Asia
China's MGI Tech takes cutting-edge DNA, Cell and Spatial Omics capabilities to Australia
MGI Australia, a subsidiary of China headquartered MGI Tech Co., a global leader in life science technology, has announced a substantial expansion of its Brisbane Customer Experience Centre (CEC), now providing Australian and New Zealand researchers first access to MGI's cutting-edge DNA, Cell and Spatial Omics (DCS) capabilities.
1 min |
BioSpectrum Asia January 2024
BioSpectrum Asia
GC Biopharma establishes mRNA production facility in Korea
GC Biopharma, a South Korean biopharmaceutical company, has completed the construction of mRNA (messenger ribonucleic acid) production facility in its own vaccine production plant in Hwasun, Jeollanam-do, Korea, and will soon start the operation.
1 min |
BioSpectrum Asia January 2024
BioSpectrum Asia
GHIT Fund injects $8.8M in new drug development projects for malaria
The Global Health Innovative Technology (GHIT) Fund, headquartered in Japan, has announced an investment of approximately 1.3 billion yen ($8.8 million) for the development of new drugs for malaria and Chagas disease
1 min |
BioSpectrum Asia January 2024
BioSpectrum Asia
MTal unveils India's historic $464M medtech FDI leap
India has witnessed a recordbreaking surge of $464 million in foreign investments in medtech in the first 3 quarters, said the Medical Technology Association of India (MTI), which represents leading researchbased medical technology companies with a large footprint in manufacturing and training in India.
1 min |
BioSpectrum Asia January 2024
BioSpectrum Asia
ADB provides $650M to support upgrading Indonesia's healthcare facilities and labs
The Asian Development Bank (ADB) has approved a $650 million investment loan to Indonesia to upgrade and enhance primary healthcare facilities and public health laboratories nationwide to improve prevention, detection, and treatment of communicable diseases, non-communicable diseases, and other health conditions
1 min |
BioSpectrum Asia January 2024
BioSpectrum Asia
WHO & India ink Traditional and Complementary Medicine Project Collaboration Agreement'
The Ministry of Ayush, Government of India, and World Health Organization (WHO) have signed a Traditional and Complementary Medicine 'Project Collaboration Agreement' in Geneva.
1 min |
BioSpectrum Asia January 2024
BioSpectrum Asia
NZ to design cancer control programme
New Zealand’s Ministry of Health’s Polynesian Health Corridors (PHC) programme is working with partners to design a multi-year cancer control programme to improve cancer outcomes in Polynesia.
1 min |
BioSpectrum Asia January 2024
BioSpectrum Asia
Australia launches first National Health & Climate Strategy
The Australian government has launched Australia's first National Health and Climate Strategy that is aimed at ensuring the health system can meet the challenges of climate change.
1 min |
BioSpectrum Asia January 2024
BioSpectrum Asia
Taiwan partners with US to develop digital health ecosystem
The Healthcare Information and Management Systems Society, US and the National Health Insurance Administration (NHIA), an agency under the Ministry of Health and Welfare of Taiwan, have formed an agreement to drive digital transformation in population health, digital capacity building, cybersecurity resilience and workforce development.
1 min |
BioSpectrum Asia January 2024
BioSpectrum Asia
INDIA'S CDMO ASCENSION
We are ushering in 2024 with a good development for the Indian pharmaceutical sector.
3 min |
BioSpectrum Asia January 2024
BioSpectrum Asia
New research unveils innovative mosquito control strategies in India
Researchers from the Indian Institute of Technology (IIT) Mandi, the Institute for Stem Cell Science and Regenerative Medicine (inStem) in Bengaluru, have discovered the biochemical processes that enable the eggs of the dengue-causing mosquito to survive harsh conditions and rejuvenate when favourable conditions return.
1 min |
BioSpectrum Asia Dec 2023
BioSpectrum Asia
Singapore offers innovative magnetic gel to heal diabetic wounds faster
Diabetic patients, whose natural wound-healing capabilities are compromised, often develop chronic wounds that are slow to heal.
1 min |
BioSpectrum Asia Dec 2023
BioSpectrum Asia
Korea develops metal-enhanced fluorescence probes for influenza A virus detection
In recent years, fluorescence-based lateral flow immunoassay (LFI) has gained popularity as a diagnostic tool for viral detection.
1 min |
BioSpectrum Asia Dec 2023
BioSpectrum Asia
Hong Kong designs multimodal robot for post-stroke ankle, foot tele-rehabilitation
The Hong Kong Polytechnic University (PolyU) has achieved another breakthrough in rehabilitation device development.
1 min |
BioSpectrum Asia Dec 2023
BioSpectrum Asia
PolyU, Hefei Luyang establish innovation research institute
The Hong Kong Polytechnic University (PolyU) and the Hefei Luyang government in China have reached an agreement to jointly establish the PolyU-Hefei Technology and Innovation Research Institute, with the aim of fostering in-depth and effective collaboration in industry, academia and research and cultivating talents.
1 min |
BioSpectrum Asia Dec 2023
BioSpectrum Asia
Porton Advanced, BioMap jointly develop gene therapies based on AAV vectors
China-based startup Porton Advanced has announced the establishment of a strategic partnership with BioMap.
1 min |
BioSpectrum Asia Dec 2023
BioSpectrum Asia
Smith+Nephew introduces REGENETEN Bioinductive Implant in Japan
British medtech company Smith+Nephew has announced the launch of its REGENETEN Bioinductive Implant allowing access to thousands of patients in Japan.
1 min |